Jinyu Bio-Technology (600201.SH): plans to purchase 2 high-performance computing Servers.

On March 26, Gelonghui reported that Jinyu Bio-Technology (600201.SH) stated on the interactive platform that to meet internal AI application needs, the company plans to purchase two high-performance computing Servers. These will be used for the private deployment of the deepseek and AlphaFold models to predict protein structures and explore applications in the Biomedical research vertical. Additionally, models using Big Data AI technology will be deployed to achieve real-time online analysis, diagnosis, and precise control of cell production processes, in order to reduce costs and increase efficiency during production.

Gelonghui FinanceMar 26 05:04 ET

Jinyu Bio-Technology (600201.SH): Currently, the domestic meat product market has not fully recovered, and the prices of meat, eggs, and milk are at a low point.

On March 20, Gelonghui reported that Jinyu Bio-Technology (600201.SH) stated on the interactive platform that the domestic meat product market consumption has not fully recovered yet, with the prices of meat, eggs, and milk at a low point, and downstream customers are still under pressure regarding cash flow, resulting in overall pressure on the Animal Protection Industry. The company leverages its solid R&D foundation and years of experience in the industry, forming differentiated competition through product iteration at the R&D level to succeed in a fiercely competitive market environment.

Gelonghui FinanceMar 20 04:37 ET

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Simply Wall StMar 4 20:10 ET

Jinyu Bio-Technology (600201.SH): A total of 3.2858 million shares of the company have been repurchased.

Glory Exchange reported on March 3 that Jinyu Bio-Technology (600201.SH) announced that as of February 28, 2025, the company had repurchased a total of 3.2858 million shares through the central bidding trading method on the Shanghai Stock Exchange, accounting for 0.2933% of the company's total share capital, with the highest transaction price at 6.54 yuan per share, the lowest transaction price at 6.37 yuan per share, and a total payment of 21.1236 million yuan (excluding commissions, transfer fees, and other transaction costs).

Gelonghui FinanceMar 3 04:17 ET

Jinyu Bio-technology Announces New Veterinary Drug Registration

MT NewswiresFeb 19 05:19 ET

Jinyu Bio-Technology (600201.SH): Exploring the application of deepseek in the field of Biological Vaccine research and development.

On February 18, Gelonghui reported that Jinyu Bio-Technology (600201.SH) stated on the interactive platform that the company is currently collaborating with top Universities and research institutions in China, widely using AI in vaccine development for tasks such as antigen screening and sequence optimization. In the future, it will continue to deeply utilize AI for target screening, process optimization, vaccine design, and high-dimensional evaluation, while also exploring the application of deepseek in the field of Biological Vaccine research and development.

Gelonghui FinanceFeb 18 05:40 ET